Back to MNPR
WELLINGTON MANAGEMENT GROUP LLP → MNPR
WELLINGTON MANAGEMENT GROUP LLP MNPR Position History
Monopar Therapeutics Inc. • Healthcare
Quarters held
20
Latest value
$400K
Q3 2026
Peak value
$6.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $6.8M |
| Q4 2025 | $125K |
| Q4 2025 | $923K |
| Q4 2025 | $6.4M |
| Q4 2025 | $549K |
| Q1 2026 | $4.3M |
| Q1 2026 | $59K |
| Q1 2026 | $643K |
| Q1 2026 | $4.1M |
| Q1 2026 | $417K |
| Q2 2026 | $6.7M |
| Q2 2026 | $141K |
| Q2 2026 | $898K |
| Q2 2026 | $6.5M |
| Q2 2026 | $436K |
| Q3 2026 | $6.3M |
| Q3 2026 | $134K |
| Q3 2026 | $925K |
| Q3 2026 | $6.1M |
| Q3 2026 | $400K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $400K | 5.0K | — | — |
| Q3 2026 | $6.1M | 76.5K | — | — |
| Q3 2026 | $925K | 11.6K | — | — |
| Q3 2026 | $134K | 1.7K | — | — |
| Q3 2026 | $6.3M | 78.9K | — | — |
| Q2 2026 | $436K | 4.7K | — | — |
| Q2 2026 | $6.5M | 70.3K | — | — |
| Q2 2026 | $898K | 9.7K | — | — |
| Q2 2026 | $141K | 1.5K | — | — |
| Q2 2026 | $6.7M | 72.2K | — | — |
| Q1 2026 | $417K | 7.6K | — | — |
| Q1 2026 | $4.1M | 74.6K | — | — |
| Q1 2026 | $643K | 11.7K | — | — |
| Q1 2026 | $59K | 1.1K | — | — |
| Q1 2026 | $4.3M | 79.3K | — | — |
| Q4 2025 | $549K | 8.4K | — | — |
| Q4 2025 | $6.4M | 97.5K | — | — |
| Q4 2025 | $923K | 14.1K | — | — |
| Q4 2025 | $125K | 1.9K | — | — |
| Q4 2025 | $6.8M | 104.2K | — | — |